EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
news

Tecentriq assumes pole position with FDA approval but Keytruda looms in triple negative breast cancer, says GlobalData

On March 8, the FDA granted the accelerated approval of Roche’s programmed cell death protein 1 (PD-1) inhibitor Tecentriq in combination with Abraxane (protein-boun...
21 March 2019 news | North America | Regional News
Continue Reading →
Europe

Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease

Approval is based on ODYSSEY OUTCOMES trial of 18,924 patients who recently suffered an acute coronary syndrome such as a heart attackPraluent is the only EU-approve...
21 March 2019 Europe | news | Regional News
Continue Reading →
news

Ardelyx’s Tenapanor may be answer to growing demand for novel CKD-MBD treatments, says GlobalData

Even though the chronic kidney disease–mineral bone disorder (CKD-MBD) market is set to face several barriers to growth over the next decade, the anticipated launch ...
21 March 2019 news | North America | Regional News
Continue Reading →
Europe

CRF Bracket Supports Remote Consenting for Virtual Clinical Studies with Latest Release of its Integrated eConsent Solution

TrialConsent extends informed consent to virtual studies for Sites, Sponsors and Patients London, UK and Philadelphia, USA – March 19, 2019:  CRF Bracket anno...
21 March 2019 Europe | news | North America
Continue Reading →
news

The flow diversion stent market is growing at a CAGR of approximately 2%, says GlobalData

Estimated to be approximately 15% of the embolization devices market, the flow diversion stent market is growing at a Compound Annual Growth Rate (CAGR) of approxima...
21 March 2019 news | North America
Continue Reading →
news

Phase III failure for Pollinex Quattro Birch puts Allergy Therapeutics in a precarious position for long-awaited US expansion, says GlobalData

On 18 March 2019, Allergy Therapeutics announced that its Phase III pivotal trial for Pollinex Quattro (PQ) Birch, an ultra-short course birch pollen allergen immuno...
21 March 2019 news | North America
Continue Reading →
Europe

SOTIO’s DCVAC/OvCa Significantly Improves Survival in Patients with Recurrent Ovarian Cancer

DCVAC/OvCa decreased the risk of death in second line treatment of ovarian cancer by 62%Overall survival (OS) increased significantly by 13.4 months. Median Pro...
21 March 2019 Europe | news | North America | Regional News
Continue Reading →
Europe

Life Sciences Companies Adopt Veeva Nitro to Eliminate the Burden of Custom Data Warehouse Development and Maintenance

Next-generation commercial data warehouse speeds implementation and automatically syncs with most important data sources BARCELONA, Spain — 19 March 2019—Veeva Sys...
19 March 2019 Europe | news | Regional News
Continue Reading →
news

Clinical Trial Supply New England Conference 2019: PCI’s Jeremy Osborne to Share his Expertise on Accelerating into Early Clinical Trials with Speed and Flexibility

Philadelphia, USA – March 14, 2019. Leading biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) will share its specialist clinical trials exper...
15 March 2019 news
Continue Reading →
Asia Pacific

FDA Green-Lights Two Therapies, While Late-Stage Successes Set Stage for Potential Approvals

The U.S. Food and Drug Administration (FDA) has been busy approving new treatments for various diseases. Two days into the new week and the regulatory agency has gre...
13 March 2019 Asia Pacific | news | North America | Regional News
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte